198 related articles for article (PubMed ID: 1997409)
1. Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.
Barington T; Kristensen K; Henrichsen J; Heilmann C
Infect Immun; 1991 Mar; 59(3):1057-64. PubMed ID: 1997409
[TBL] [Abstract][Full Text] [Related]
2. Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity.
Barington T; Juul L; Gyhrs A; Heilmann C
Infect Immun; 1994 Aug; 62(8):3066-74. PubMed ID: 8039873
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of antibody-secreting cells in the blood after vaccination with Haemophilus influenzae type b conjugate vaccine.
Barington T; Heilmann C; Andersen V
Scand J Immunol; 1990 Apr; 31(4):515-22. PubMed ID: 2185534
[TBL] [Abstract][Full Text] [Related]
4. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
5. In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate.
Peeters CC; Tenbergen-Meekes AM; Heijnen CJ; Poolman JT; Zegers BJ; Rijkers GT
J Immunol; 1991 Dec; 147(12):4192-9. PubMed ID: 1753096
[TBL] [Abstract][Full Text] [Related]
6. In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide.
Munoz JL; Insel RA
J Immunol; 1987 Sep; 139(6):2026-31. PubMed ID: 3040862
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
[TBL] [Abstract][Full Text] [Related]
8. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
9. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
Jelonek MT; Chang SJ; Chiu CY; Park MK; Nahm MH; Ward JI
Infect Immun; 1993 Dec; 61(12):5345-50. PubMed ID: 8225608
[TBL] [Abstract][Full Text] [Related]
10. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of the immune response of infants to three Haemophilus influenzae type b vaccines.
Turner RB; Cimino CO; Sullivan BJ
Pediatr Infect Dis J; 1991 Feb; 10(2):108-12. PubMed ID: 2062600
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
Lepow ML; Samuelson JS; Gordon LK
J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
[TBL] [Abstract][Full Text] [Related]
13. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
[TBL] [Abstract][Full Text] [Related]
14. Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination.
Carlsson RM; Claesson BA; Lagergård T; Käyhty H
Scand J Infect Dis; 1996; 28(5):519-23. PubMed ID: 8953685
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
16. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
17. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
Gordon LK
Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
[TBL] [Abstract][Full Text] [Related]
18. Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.
Eskola J; Käyhty H; Peltola H; Karanko V; Mäkelä PH; Samuelson J; Gordon LK
Lancet; 1985 May; 1(8439):1184-6. PubMed ID: 2860387
[TBL] [Abstract][Full Text] [Related]
19. Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components.
Barington T; Skettrup M; Juul L; Heilmann C
Infect Immun; 1993 Feb; 61(2):432-8. PubMed ID: 7678586
[TBL] [Abstract][Full Text] [Related]
20. Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine.
Cates KL; Marsh KH; Granoff DM
Infect Immun; 1985 Apr; 48(1):183-9. PubMed ID: 3872263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
